Aarey Drugs & Pharmaceuticals Limited - Asset Resilience Ratio
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has an Asset Resilience Ratio of 0.34% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Aarey Drugs & Pharmaceuticals Limited strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how Aarey Drugs & Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. See AAREYDRUGS equity to assets ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Aarey Drugs & Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Aarey Drugs & Pharmaceuticals Limited market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs9.99 Million | 0.34% |
| Total Liquid Assets | Rs9.99 Million | 0.34% |
Asset Resilience Insights
- Limited Liquidity: Aarey Drugs & Pharmaceuticals Limited maintains only 0.34% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Aarey Drugs & Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio
Compare Aarey Drugs & Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
SIMCERE PHARMAC. GRP LTD
F:S2P |
Drug Manufacturers - Specialty & Generic | 0.44% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
Annual Asset Resilience Ratio for Aarey Drugs & Pharmaceuticals Limited (2013–2025)
The table below shows the annual Asset Resilience Ratio data for Aarey Drugs & Pharmaceuticals Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.74% | Rs17.56 Million ≈ $189.92K |
Rs2.38 Billion ≈ $25.77 Million |
+0.31pp |
| 2024-03-31 | 0.43% | Rs12.95 Million ≈ $140.09K |
Rs3.03 Billion ≈ $32.80 Million |
+0.28pp |
| 2023-03-31 | 0.14% | Rs4.18 Million ≈ $45.21K |
Rs2.91 Billion ≈ $31.51 Million |
-2.92pp |
| 2022-03-31 | 3.06% | Rs75.07 Million ≈ $811.83K |
Rs2.45 Billion ≈ $26.51 Million |
+3.06pp |
| 2021-03-31 | 0.01% | Rs129.95K ≈ $1.41K |
Rs2.33 Billion ≈ $25.20 Million |
0.00pp |
| 2020-03-31 | 0.01% | Rs154.05K ≈ $1.67K |
Rs1.94 Billion ≈ $20.99 Million |
-0.01pp |
| 2019-03-31 | 0.02% | Rs232.72K ≈ $2.52K |
Rs1.46 Billion ≈ $15.76 Million |
-1.67pp |
| 2018-03-31 | 1.69% | Rs28.66 Million ≈ $309.95K |
Rs1.70 Billion ≈ $18.36 Million |
+1.39pp |
| 2017-03-31 | 0.30% | Rs4.34 Million ≈ $46.91K |
Rs1.43 Billion ≈ $15.49 Million |
+0.27pp |
| 2015-03-31 | 0.03% | Rs400.00K ≈ $4.33K |
Rs1.15 Billion ≈ $12.43 Million |
0.00pp |
| 2014-03-31 | 0.04% | Rs400.00K ≈ $4.33K |
Rs1.07 Billion ≈ $11.56 Million |
+0.00pp |
| 2013-03-31 | 0.04% | Rs400.00K ≈ $4.33K |
Rs1.07 Billion ≈ $11.58 Million |
-- |
About Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl… Read more